Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5801–5850 of 18416
On March 24, 2024, Richard Roedel, the Chairman of the Board of Directors (the "Board") of Luna Innovations Incorporated (the "Company"), was appointed Interim Executive Chairman and Interim President, effective immediately
On March 25, 2024, the Company appointed Marjorie Hargrave as its new Chief Financial Officer, effective April 10, 2024, to succeed Lawrence D. Martin.
On March 25, 2024, the Company appointed Marjorie Hargrave as its new Chief Financial Officer, effective April 10, 2024, to succeed Lawrence D. Martin.
Effective March 18, 2024, the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) appointed Adam Desmond to the position of Chief Executive Officer.
On March 21, 2024, the Board of Trustees of Sterling Real Estate Trust (the “Trust”) appointed Megan E. Schreiner as interim-Chief Financial Officer of the Trust, effective April 1, 2024.
Alan Gahm, who has been serving as the Company’s Interim Chief Financial Officer since January 2024 will step down from his role as the Interim Chief Financial Officer upon the effectiveness of Mr. Morris’s appointment.
On March 25, 2024, the Company announced that Phelps Morris has been appointed to serve as Chief Financial Officer of the Company, effective April 1, 2024 (the "Effective Date").
Chris Guo had been appointed the Company’s Interim Chief Financial Officer (“Interim CFO”) effective as of March 15, 2024.
Kimberly A. Adams has notified the Company that she will retire as Vice President and Chief Financial Officer of the Company and the Bank effective as of May 31, 2024.
appointed James Campanaro, the current Vice President of Accounting of the Bank, as Chief Financial Officer of the Company and the Bank, effective as of May 31, 2024.
James Berg, current Controller of the Company, was appointed to serve as the Chief Financial Officer of the Company beginning April 1, 2024.
Peter Poli, Chief Financial Officer of Track Group, Inc. (the “ Company ”), has informed the Company of his intention to resign from his position as Chief Financial Officer of the Company, effective March 31, 2024.
On November 16, 2023, John Gorst was terminated as CEO and as a Board Member.
On March 19, 2024, Mr. Deitsch submitted a letter of resignation to our Board of Directors and thereby resigned as Chief Executive Officer, Director, Chairman of the Board, and Chief Financial Officer of Nutra Pharma Corp., effective immediately.
On March 20, 2024, our Board of Directors unanimously approved of the appointment of Michael Flax, DDS as our Chief Executive Officer, Director, Chairman of the Board and Chief Financial Officer.
the Boards of Directors of Peoples and Peoples Bank elected Tyler J. Wilcox to serve as the next President and CEO of each of Peoples and Peoples Bank effective April 1, 2024, following Mr. Sulerzyski’s retirement.
Charles W. Sulerzyski will retire as President and Chief Executive Officer (“CEO”) and as a director of Peoples and Peoples Bank effective as of March 31, 2024.
who is resigning effective as of March 31, 2024, for personal reasons.
appointed Matthew J. D’Onofrio as the Company’s Chief Executive Officer, effective as of March 31, 2024.
Paul Josephs has been elected as the Company’s President and Chief Executive Officer effective May 20, 2024
Mr. Josephs will succeed James G. Hall, the Company’s current President and Chief Executive Officer.
Upon the effectiveness of Mr. Bentley’s transition, the Board will appoint Nicholas H. Cumins, the Company’s Chief Operating Officer, as Chief Executive Officer.
transition of Relland M. Winand from the role of interim Chief Financial Officer, also effective as of April 8, 2024
announced the appointment of Jeffrey DiGiovanni to the position of Chief Financial Officer, effective as of April 8, 2024
Randy Garutti who, as previously disclosed, will resign as Chief Executive Officer and as a member of the Board as of the Effective Date
the Board of Directors (the “ Board ”) of Shake Shack Inc. (“ Shake Shack ”) appointed Robert Lynch to serve as its Chief Executive Officer, effective as of May 20, 2024
On March 18, 2024, Robert M. Lynch informed the Board of Directors (the “Board”) of Papa John’s International, Inc. (the “Company”) of his decision to resign from his position as President and Chief Executive Officer of the Company and as a director of the Board, in each case effective March 20, 2024, to assume a chief executive officer role with another company.
the Board appointed Ravi Thanawala, the Company’s Chief Financial Officer, to the additional position of interim Chief Executive Officer, effective March 20, 2024.
On March 18, 2024, Thomas H. Mayrhofer was appointed the Chief Financial Officer and Treasurer of DigitalBridge Group, Inc.
Mr. Wu ceased to serve as the Company’ Executive Vice President, Chief Financial Officer and Treasurer on May 18, 2024 and has agreed to continue to serve as an employee of the Company providing strategic advice through June 30, 2024 pursuant to the employment agreement between the Company and Mr. Wu dated as of November 13, 2023.
On March 20, 2024, Bio-Rad Laboratories, Inc. (the “Company”) announced the appointment by the Board of Directors of the Company of Roop K. Lakkaraju as the Company’s Executive Vice President, Chief Financial Officer (including as principal financial officer), effective April 15, 2024.
On March 15, 2024, Dan Chevallard informed Viracta Therapeutics, Inc. (the “Company”) that he was resigning from his positions as Chief Financial Officer and Chief Operating Officer of the Company, effective on March 20, 2024, to pursue other opportunities.
Effective upon Mr. Chevallard’s resignation as Chief Financial Officer and Chief Operating Officer, Melody Burcar, the Company’s Senior Vice President of Finance, will serve as the Company’s interim principal financial officer and interim principal accounting officer while the Company engages in a search for a permanent replacement for Mr. Chevallard.
Lauren Budden, who has been serving as the Company’s Interim CFO and Treasurer, will step down as Interim CFO and Treasurer and continue in her role as Group Vice President, Chief Accounting Officer and Controller.
On March 20, 2024, Insulet Corporation (the “ Company ”) announced the appointment, effective April 22, 2024, of Ana Maria Chadwick to serve as Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer.
On March 17, 2024, Alex Amezquita ceased to serve as the Company’s Chief Financial Officer but will continue to serve as an employee of the Company.
On March 17, 2024, John DeSimone was appointed as the Company’s Chief Financial Officer.
On March 20, 2024, the Company appointed co-founder and current Chief Product Officer, Clint Sever, as Chief Executive Officer.
On March 19, 2024, Cue Health Inc. (the “Company”) announced that Ayub Khattak is stepping down as Chief Executive Officer, President and Chairman of the Board, effective immediately.
On March 12, 2024, the Company elected to not renew the terms of its current Chief Executive Officer’s, Paul O’Brien, Employment Agreement dated as of May 26, 2023
the Board of Directors of the Company appointed Steven Handwerker as Chief Financial Officer of the Company.
On March 16, the Board of Directors selected the following Executive Officers to serve until the annual meeting in January 2025, or until successors are elected and have qualified. President George Pappi, Jr. Executive Vice President Karen King Vice President – Finance / Chief Financial Officer Suzanne Colvin Vice President – Operations Rodney Enns Vice President – Secretary Gary Willems
Mr. Ball assumes the role of principal accounting officer from Julia Wang, the Company’s Chief Financial Officer, who previously served as the Company’s principal financial officer and principal accounting officer.
On March 15, 2024, the Company appointed John Witek, the Company’s Vice President, Global Business Services, as interim Chief Financial Officer, effective March 19, 2024.
On March 13, 2024, Ana Maria Chadwick, Executive Vice President and Chief Financial Officer of Pitney Bowes Inc. (the “Company”), informed the Company that she would be resigning from her position of Executive Vice President and Chief Financial Officer.
On March 19, 2024, Benchmark Electronics, Inc. (NYSE: BHE) announced that Roop K. Lakkaraju, Executive Vice President and Chief Financial Officer (“CFO”) and Principal Accounting Officer (“PAO”), intends to resign from his position effective April 1, 2024 to pursue a professional opportunity outside of Benchmark.
Effective April 1, 2024, Arvind Kamal, who has served as the Vice President of Finance of the Company for the past four years, will be named Interim CFO and PAO.
Effective March 17, 2024, Mr. Jon Niermann (“ Mr. Niermann ”), the Company’s Founder and Chief Executive Officer (“ CEO ”), stepped down from his position as CEO but will continue to serve as a member of the Board and the management team of the Company and has taken on a role to assist the Company with outward-facing sales and distribution efforts and to ensure an orderly transition for his successor.
On March 18, 2024, Bakkt Holdings, Inc. (the “Company”) announced that the Company’s Board of Directors (the “Board”) appointed Andrew Main to serve as the Company’s President and Chief Executive Officer, effective as of March 26, 2024.
Mr. Main will succeed Gavin Michael, the Company’s current President and Chief Executive Officer, who will remain with the Company as an advisor for a period of one year.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.